Invesco EQV International Equity Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-05-09 08:40:00 ET
Summary
- Class A shares underperformed the MSCI ACWI ex USA Index.
- In a market environment where value stocks led, the fund’s long-term, conservative growth strategy faced headwinds.
- During the quarter, we initiated eight new positions and exited five stocks based on our EQV fundamentals.
- Regardless of the macroeconomic environment, we remain focused on applying our well-established, long-term, bottom-up EQV investment process that seeks to identify attractively valued, high quality growth companies.
...
Read the full article on Seeking Alpha
For further details see:
Invesco EQV International Equity Fund Q1 2025 Commentary
AstraZeneca PLC
NASDAQ: AZN
AZN Trading
9.5% G/L:
$93.12 Last:
2,417,086 Volume:
$93.03 Open:
AZN Latest News
March 10, 2026 08:30:00 am
AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer
March 09, 2026 08:05:00 am
Koselugo approved in Canada for plexiform neurofibromas in adults with neurofibromatosis type 1
AZN Stock Data
$606,922,468,616
3,070,437,221
0.1%
781
N/A
Pharmaceuticals
Healthcare
GB
Cambridge
